Log in to search using one of your social media accounts:

 

Risk of breast cancer recurrence lasts for decades
(Reuters Health) - Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Stopping HRT after menopause may increase cardiovascular disease risk
Research published inMenopause reports that women who stop hormone therapy after menopause are at higher risk of cardiac and stroke death.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 17, 2017 Category: Endocrinology Source Type: news

CV Deaths in Younger Women Rise During Year After Stopping HT CV Deaths in Younger Women Rise During Year After Stopping HT
Women younger than 60 years had a higher risk for cardiac and stroke death during the first year after stopping hormone therapy compared with those not taking HT and those continuing HT, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells
(Rapamycin Press) An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta, according to research published in Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Risk of breast cancer recurring persists after end of hormone therapy
According to a study, published in theNew England Journal of Medicine, women successfully treated for breast cancer with hormone therapy still have an increased risk of it returning, even 15 years after hormone therapy ended.Newsweek  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 10, 2017 Category: Endocrinology Source Type: news

Growth-hormone Therapy Does Not Raise Heart Risks in Adulthood Growth-hormone Therapy Does Not Raise Heart Risks in Adulthood
Growth-hormone treatment during childhood does not increase young adults ’ cardiovascular disease (CVD) risk, but it improves their lipid profiles, according to industry-funded research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Breast cancer 'can return 15 years after treatment ends'
Extending treatment with hormone therapy could reduce the risk of it recurring. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 9, 2017 Category: Consumer Health News Source Type: news

Stopping hormone therapy increases risk of cardiac complications
According to a study, published inMenopause, discontinuing hormone therapy increases the risk of heart–related complications and stroke.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 9, 2017 Category: Endocrinology Source Type: news

Risk of cardiac and stroke death increases after discontinuing hormone therapy
(The North American Menopause Society (NAMS)) Hormone therapy (HT) continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted. A new study demonstrates that the risk of cardiac and stroke death actually increases in the first year after discontinuation of HT. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Hormone Therapy for Menopausal Women in Primary Care Hormone Therapy for Menopausal Women in Primary Care
A better understanding of menopausal hormone therapy will help primary care providers adequately counsel and treat women suffering from vasomotor symptoms.Journal for Nurse Practitioners (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news

Living With Cancer: Treating prostate cancer
Hormone therapy for prostate cancer? Most prostate cancer cells rely on testosterone to help them grow. Hormone therapy for prostate cancer, also called androgen deprivation therapy, is treatment to stop the male hormone testosterone from reaching prostate cancer cells in your body. Learn about how the therapy works, the possible side effects and risks, and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 3, 2017 Category: Databases & Libraries Source Type: news

Women's Wellness: Hormone therapy and Alzheimer's disease
Introducing hormone treatment for women in early stages of menopause might help decrease their risk of dementia or Alzheimer's disease. For women, a drop in hormones during midlife may have some influence on developing dementia or Alzheimer's disease. Also, general brain volume gradually declines with advancing age, but the decline is faster in people who [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 2, 2017 Category: Databases & Libraries Source Type: news

Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer
ROCHESTER, Minn. ? Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers to individualized treatments for castration-resistant prostate cancer, a deadly disease that does not respond to standard hormone therapy. Several U.S. [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - November 1, 2017 Category: Research Source Type: news

Misconceptions About Hormone Therapy Persist Misconceptions About Hormone Therapy Persist
Many professionals in ob/gyn clinical practice reportedly lack understanding about hormone therapy and about data from the Women's Health Initiative trials, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Changing the Conversation About Hormone Therapy Changing the Conversation About Hormone Therapy
This brief report summarizes the 2017 Hormone Therapy Position Statement of The North American Menopause Society, which emphasizes an individualized, evidence-based approach.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Is It Time to Rethink Hormone Therapy?
(MedPage Today) -- Study suggests risks may be overstated (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 23, 2017 Category: American Health Source Type: news

Medical News Today: Hormone therapy for prostate cancer increases cardiac risk
Androgen-deprivation therapy is widely used to treat prostate cancer. In a recent study, the potential risks to heart health are examined. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 18, 2017 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

' Change the Conversation' About Hormone Therapy in Menopause'Change the Conversation' About Hormone Therapy in Menopause
The North American Menopause Society's new position statement on hormone therapy is in the spotlight here at the 2017 annual meeting, where fears about treatment are being appeased.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

NAMS:'Take the Fear Out' of Hormone Therapy
(MedPage Today) -- JoAnn Pinkerton, MD, breaks down the highlights of NAMS updated position statement (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 13, 2017 Category: Endocrinology Source Type: news

Hormones may be safe migraine treatment for elderly
Hormone therapy may be safe and effective for treating migraine in the elderly, according to a study presented at the North American Menopause Society Annual Meeting.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 13, 2017 Category: Endocrinology Source Type: news

Life after cancer: “The real battle happened after treatment”
Bin McLaurin was lucky. Doctors detected his prostate cancer early, and he successfully completed the surgery, radiation and hormone therapy he needed to keep the disease at bay.But two years out from his 2014 diagnosis, McLaurin didn't feel so great. He had gained 60 pounds during treatment,... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - October 12, 2017 Category: Science Authors: Eryn Brown Source Type: news

Hormone Therapy May Be OK for Women With Migraines
Title: Hormone Therapy May Be OK for Women With MigrainesCategory: Health NewsCreated: 10/11/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - October 12, 2017 Category: Neurology Source Type: news

Hormone therapy may be OK for women with migraines
Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 12, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy May Be OK for Women With Migraines
Heightened risk of stroke not borne out in preliminary study (Source: WebMD Health)
Source: WebMD Health - October 11, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy May Be OK for Women With Migraines
WEDNESDAY, Oct. 11, 2017 -- Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. The study of 85,000 U.S. women found no evidence that hormone therapy carried a particular risk... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 11, 2017 Category: General Medicine Source Type: news

Despite effectiveness women remain skeptical of hormones at menopause -- what's the problem?
(The North American Menopause Society (NAMS)) Women today have more options than ever before for treating their menopause symptoms, although hormone therapy still ranks as the most effective treatment for debilitating symptoms such as hot flashes. A new study demonstrates, however, that women remain skeptical regarding the safety of hormone therapy and prefer less proven options. The study results will be presented during The North American Menopause Society (NAMS) Annual Meeting in Philadelphia, Oct. 11-14. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 11, 2017 Category: International Medicine & Public Health Source Type: news

Health Canada accepts marketing application for Mithra ’s hormone therapy Tibelia
Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra ’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 10, 2017 Category: Pharmaceuticals Source Type: news

Hormone Therapy and Technology Headline NAMS Meeting Hormone Therapy and Technology Headline NAMS Meeting
The theme of technology will run through the North American Menopause Society (NAMS) meeting, but hormone therapy, breast imaging, lesbian health, and vaginal health are also on the agenda.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 5, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Transgender Hockey Player Postpones Hormone Treatment To Keep Playing
Sports leagues have struggled with how to define gender when it comes to deciding who can play. Pro hockey player Harrison Browne has decided to postpone hormone therapy for one more year on the ice.(Image credit: Courtesy of the National Women's Hockey League) (Source: NPR Health and Science)
Source: NPR Health and Science - September 24, 2017 Category: Consumer Health News Authors: Maggie Mertens Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include hospital factors relevant to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 16, 2017 Category: American Health Source Type: news

Diabetes Drugs' CV Effects; Hormone Therapy; Aneurysms Reduced with T2D?
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 15, 2017 Category: Cardiology Source Type: news

Menopause hormone therapy not linked to premature death
According to a study published inJAMA, women who take hormone replacement therapy may be no more likely to die prematurely than women who do not take hormones.Reuters  (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 14, 2017 Category: Endocrinology Source Type: news

Hormone Therapy Isn't As Risky As Once Thought, New Study Finds
Good news for menopausal women. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 13, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy Isn't As Risky As Once Thought, New Study Finds
Good news for menopausal women. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 13, 2017 Category: Consumer Health News Source Type: news

Could hormone therapy for menopause make a comeback?
New research suggests the hormone therapy won't increase risk of early death (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 13, 2017 Category: Consumer Health News Source Type: news

Diabetes Targets Hard to Meet in Transgender Population
(MedPage Today) -- Hormone therapy tied to increased modi?able risks (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 13, 2017 Category: Primary Care Source Type: news

Hormone therapy does not increase risk of cancer
Harvard Medical School did a follow-up on a 90s study that claimed hormone therapy caused risk of heart disease, cancers and premature death. It showed the risks were not caused by the drug. (Source: the Mail online | Health)
Source: the Mail online | Health - September 13, 2017 Category: Consumer Health News Source Type: news

Up to 7 years of hormone therapy is safe for postmenopausal women, new data show
For decades now, women navigating menopause have been buffeted by shifting research findings on the risks and possible benefits of hormone-replacement therapy. Now, a landmark clinical trial that followed more than 27,000 subjects for roughly 18 years has offered some conclusive evidence that neither... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - September 12, 2017 Category: Science Authors: Melissa Healy Source Type: news

Menopausal Hormone Therapy Not Associated with Mortality Risk (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Menopausal hormone therapy does not put women at increased risk for death, according to long-term follow-up from the Women's Health … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 12, 2017 Category: Primary Care Source Type: news

Menopause hormone therapy not linked to premature death
(Reuters Health) - Women who take hormone replacement therapy (HRT) to ease menopause symptoms like hot flashes and night sweats may be no more likely to die prematurely than women who don ’t take hormones, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Hormone therapy does notincrease risk of cancer
Harvard Medical School did a follow-up on a 90s study that claimed hormone therapy caused risk of heart disease, cancers and premature death. It showed the risks were not caused by the drug. (Source: the Mail online | Health)
Source: the Mail online | Health - September 12, 2017 Category: Consumer Health News Source Type: news

Why Hormone Replacement Therapy May Be Safer Than You Think
The pendulum has swung from one extreme to the other when it comes to hormone replacement therapy (HRT) to treat symptoms of menopause. At first, the replacement hormones—mostly a combination of estrogen and progestin to replace what the body stops making after menopause—were seen as a panacea. Doctors thought they could not only relieve hot flashes and night sweats, but also prevent chronic aging diseases like heart problems and weakening bones. But studies then found that the supplement hormones could lead to a higher risk of breast cancer—and that they didn’t protect the heart after all. In the l...
Source: TIME.com: Top Science and Health Stories - September 12, 2017 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs estrogen Hormone Therapy hormones for menopause hot flashes night sweats progestin Reproductive Health treating menopause Source Type: news

Hormone Therapy: No Excess Mortality in 18-Year WHI Follow-up Hormone Therapy: No Excess Mortality in 18-Year WHI Follow-up
Cardiovascular mortality, total cancer mortality, and all-cause mortality all remained statistically similar among women who did and did not use hormone therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 12, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Menopausal Hormone Therapy: Why Mortality Outcomes Are ‘ Vital ’ Menopausal Hormone Therapy: Why Mortality Outcomes Are ‘ Vital ’
Dr JoAnn Manson is the lead author of a new report that examined all-cause and cause-specific mortality among women who have taken hormone replacement therapy for menopausal symptoms.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Menopausal hormone therapy not associated with mortality or deaths from CVD
(Brigham and Women's Hospital) In the overall study of women ages 50-79, researchers found no increase or decrease in total mortality or deaths from cardiovascular disease, cancer or other major illnesses in the randomized hormone therapy trials. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 12, 2017 Category: Cancer & Oncology Source Type: news

Managing Pain Can Be a Puzzle After Breast Cancer
Women who take opioids are more likely to stop vital hormonal therapy, study finds (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 11, 2017 Category: Cancer & Oncology Tags: Endocrinology, Oncology, Pharmacy, News, Source Type: news

Managing Pain Can Be a Puzzle After Breast Cancer
Women who take opioids are more likely to stop vital hormonal therapy, study finds Source: HealthDay Related MedlinePlus Pages: Breast Cancer, Pain Relievers, Seniors' Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 11, 2017 Category: Consumer Health News Source Type: news

Managing Pain Can Be a Puzzle After Breast Cancer
Women who take opioids are more likely to stop vital hormonal therapy, study finds (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - September 11, 2017 Category: Cancer & Oncology Source Type: news

Patients with high risk prostate cancer may benefit 'equally' from two new treatments
(European Society for Medical Oncology) Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new treatments, according to late-breaking results from the STAMPEDE trial presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news